Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and Daclatasvir for Pediatric HCV Genotype 4
NCT03080415Phase 3Completed
- Sponsor
- Yassin Abdelghaffar Charity Center for Liver Disease and Research
- Start
- Mar 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir, daclatasvir in hepatitis C (HCV), sponsored by Yassin Abdelghaffar Charity Center for Liver Disease and Research. Started Mar 2017; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03080415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080415.